These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 22079761

  • 21. Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors.
    Caldwell CG, Chen P, He J, Parmee ER, Leiting B, Marsilio F, Patel RA, Wu JK, Eiermann GJ, Petrov A, He H, Lyons KA, Thornberry NA, Weber AE.
    Bioorg Med Chem Lett; 2004 Mar 08; 14(5):1265-8. PubMed ID: 14980678
    [Abstract] [Full Text] [Related]

  • 22. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
    Wu WL, Burnett DA, Caplen MA, Domalski MS, Bennett C, Greenlee WJ, Hawes BE, O'Neill K, Weig B, Weston D, Spar B, Kowalski T.
    Bioorg Med Chem Lett; 2006 Jul 15; 16(14):3674-8. PubMed ID: 16690315
    [Abstract] [Full Text] [Related]

  • 23. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
    Tsai TY, Coumar MS, Hsu T, Hsieh HP, Chien CH, Chen CT, Chang CN, Lo YK, Wu SH, Huang CY, Huang YW, Wang MH, Wu HY, Lee HJ, Chen X, Chao YS, Jiaang WT.
    Bioorg Med Chem Lett; 2006 Jun 15; 16(12):3268-72. PubMed ID: 16581245
    [Abstract] [Full Text] [Related]

  • 24. 5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk).
    Winters MP, Robinson DJ, Khine HH, Pullen SS, Woska JR, Raymond EL, Sellati R, Cywin CL, Snow RJ, Kashem MA, Wolak JP, King J, Kaplita PV, Liu LH, Farrell TM, DesJarlais R, Roth GP, Takahashi H, Moriarty KJ.
    Bioorg Med Chem Lett; 2008 Oct 15; 18(20):5541-4. PubMed ID: 18823779
    [Abstract] [Full Text] [Related]

  • 25. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
    Qian Y, Wertheimer SJ, Ahmad M, Cheung AW, Firooznia F, Hamilton MM, Hayden S, Li S, Marcopulos N, McDermott L, Tan J, Yun W, Guo L, Pamidimukkala A, Chen Y, Huang KS, Ramsey GB, Whittard T, Conde-Knape K, Taub R, Rondinone CM, Tilley J, Bolin D.
    J Med Chem; 2011 Apr 14; 54(7):2433-46. PubMed ID: 21413799
    [Abstract] [Full Text] [Related]

  • 26. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
    Yun W, Ahmad M, Chen Y, Gillespie P, Conde-Knape K, Kazmer S, Li S, Qian Y, Taub R, Wertheimer SJ, Whittard T, Bolin D.
    Bioorg Med Chem Lett; 2011 Dec 01; 21(23):7205-9. PubMed ID: 22001092
    [Abstract] [Full Text] [Related]

  • 27. 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1).
    Lim CJ, Kim SH, Lee BH, Oh KS, Yi KY.
    Bioorg Med Chem Lett; 2012 Jan 01; 22(1):427-30. PubMed ID: 22137790
    [Abstract] [Full Text] [Related]

  • 28. 5-sulfonyl-benzimidazoles as selective CB2 agonists-part 2.
    Gijsen HJ, De Cleyn MA, Surkyn M, Van Lommen GR, Verbist BM, Nijsen MJ, Meert T, Wauwe JV, Aerssens J.
    Bioorg Med Chem Lett; 2012 Jan 01; 22(1):547-52. PubMed ID: 22130134
    [Abstract] [Full Text] [Related]

  • 29. Novel benzimidazole-based MCH R1 antagonists.
    Carpenter AJ, Al-Barazanji KA, Barvian KK, Bishop MJ, Britt CS, Cooper JP, Goetz AS, Grizzle MK, Hertzog DL, Ignar DM, Morgan RO, Peckham GE, Speake JD, Swain WR.
    Bioorg Med Chem Lett; 2006 Oct 01; 16(19):4994-5000. PubMed ID: 16904318
    [Abstract] [Full Text] [Related]

  • 30. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin.
    Zong J, Pollack GM.
    J Pharmacol Exp Ther; 2003 Aug 01; 306(2):556-62. PubMed ID: 12721332
    [Abstract] [Full Text] [Related]

  • 31. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
    Hall A, Billinton A, Bristow AK, Brown SH, Chowdhury A, Cutler L, Giblin GM, Goldsmith P, Hayhow TG, Kilford IR, Naylor A, Passingham B, Rawlings DA.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):4027-32. PubMed ID: 18571922
    [Abstract] [Full Text] [Related]

  • 32. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV, Sateesh K, Panchagnula R.
    Mol Pharm; 2005 Jul 15; 2(1):12-21. PubMed ID: 15804173
    [Abstract] [Full Text] [Related]

  • 33. The development and SAR of pyrrolidine carboxamide 11beta-HSD1 inhibitors.
    Cheng H, Hoffman J, Le P, Nair SK, Cripps S, Matthews J, Smith C, Yang M, Kupchinsky S, Dress K, Edwards M, Cole B, Walters E, Loh C, Ermolieff J, Fanjul A, Bhat GB, Herrera J, Pauly T, Hosea N, Paderes G, Rejto P.
    Bioorg Med Chem Lett; 2010 May 01; 20(9):2897-902. PubMed ID: 20363126
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis.
    Hernández-Luis F, Hernández-Campos A, Castillo R, Navarrete-Vázquez G, Soria-Arteche O, Hernández-Hernández M, Yépez-Mulia L.
    Eur J Med Chem; 2010 Jul 01; 45(7):3135-41. PubMed ID: 20430484
    [Abstract] [Full Text] [Related]

  • 35. Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.
    Miller JF, Turner EM, Gudmundsson KS, Jenkinson S, Spaltenstein A, Thomson M, Wheelan P.
    Bioorg Med Chem Lett; 2010 Apr 01; 20(7):2125-8. PubMed ID: 20207537
    [Abstract] [Full Text] [Related]

  • 36. Influence of time to achieve substrate distribution equilibrium between brain tissue and blood on quantitation of the blood-brain barrier P-glycoprotein effect.
    Padowski JM, Pollack GM.
    Brain Res; 2011 Dec 02; 1426():1-17. PubMed ID: 22036081
    [Abstract] [Full Text] [Related]

  • 37. Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics.
    Lagas JS, Vlaming ML, van Tellingen O, Wagenaar E, Jansen RS, Rosing H, Beijnen JH, Schinkel AH.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6125-32. PubMed ID: 17062689
    [Abstract] [Full Text] [Related]

  • 38. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
    Kwan P, Brodie MJ.
    Epilepsia; 2005 Feb 15; 46(2):224-35. PubMed ID: 15679503
    [Abstract] [Full Text] [Related]

  • 39. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.
    Zhao R, Pollack GM.
    Biochem Pharmacol; 2009 Oct 15; 78(8):1052-9. PubMed ID: 19523457
    [Abstract] [Full Text] [Related]

  • 40. Discovery of triazine-benzimidazoles as selective inhibitors of mTOR.
    Peterson EA, Andrews PS, Be X, Boezio AA, Bush TL, Cheng AC, Coats JR, Colletti AE, Copeland KW, DuPont M, Graceffa R, Grubinska B, Harmange JC, Kim JL, Mullady EL, Olivieri P, Schenkel LB, Stanton MK, Teffera Y, Whittington DA, Cai T, La DS.
    Bioorg Med Chem Lett; 2011 Apr 01; 21(7):2064-70. PubMed ID: 21376583
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.